| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |